Establishment Labs - ESTA Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings or view top-rated stocks.

3 brokers have issued 1 year price targets for Establishment Labs' shares. Their ESTA share price forecasts range from $65.00 to $125.00. On average, they expect the company's share price to reach $99.00 in the next year. This suggests a possible upside of 51.4% from the stock's current price.
View analysts price targets for ESTA or view top-rated stocks among Wall Street analysts.

Establishment Labs' stock was trading at $67.59 at the start of the year. Since then, ESTA stock has decreased by 3.2% and is now trading at $65.40.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our ESTA earnings forecast.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by $0.27. The business earned $29.04 million during the quarter, compared to the consensus estimate of $27.50 million. Establishment Labs had a negative trailing twelve-month return on equity of 129.28% and a negative net margin of 49.94%. During the same period last year, the business posted ($0.18) earnings per share.

Establishment Labs issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $155.00 million-$165.00 million, compared to the consensus revenue estimate of $161.73 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional investors include Brown Advisory Inc. (6.77%), Cowen AND Company LLC (3.46%), Artisan Partners Limited Partnership (1.20%), Kornitzer Capital Management Inc. KS (1.16%), Assenagon Asset Management S.A. (0.66%) and Affinity Asset Advisors LLC (0.00%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Renee Gaeta and Santos Salvador Dada.
View institutional ownership trends.

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ESTA stock can currently be purchased for approximately $65.40.

Establishment Labs (NASDAQ:ESTA) has a market capitalization of $1.58 billion and generates $126.68 million in revenue each year. The company earns $-41,140,000.00 in net income (profit) each year or ($2.96) on an earnings per share basis.

The company employs 746 workers across the globe.

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The official website for the company is www.establishmentlabs.com. The company can be reached via phone at (062) 434-2400 or via email at ir@establishmentlabs.com.